Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $477.2M |
| Sales growthchange from the year before | +3.0% |
| Gross marginshare of sales left after the direct cost of what it sells | 68.7% |
| Operating marginshare of sales left after running the business | -1140.8% |
| Net marginshare of sales kept as profit | -806.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | -15.8% |
| Return on invested capitalprofit made on each $100 put into the business | -8.2% |
| Return on equityprofit vs. shareholders' accounting value | -8.7% |
| Debt / equitydebt vs. shareholders' accounting value | 0.19 |
| Change in share countnegative = the company is buying back its shares | +44.2% |
1 insider sold $497K on the open market.
| Patten Jarrod MDirector | SoldJul 27 | 1,950 shat $98.48 · $192K |
| Patten Jarrod MDirector | SoldJul 24 | 1,950 shat $92.45 · $180K |
| Patten Jarrod MDirector | SoldJul 22 | 1,250 shat $100.00 · $125K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy